Mount Desert Island Hospital and Penn Medicine are hosting a collaborative program discussing the advances in cancer research and healthy brain aging at the Asticou Inn in Northeast Harbor on Monday, Aug. 6.
The event is open to the public and features presentations by senior physicians from Penn Medicine and MDI Hospital on topics including successful brain aging, extending the quality of life in older adults, new drug discoveries, the importance of communications when delivering a cancer diagnosis, and innovations in individualized cancer care.
Partners in Patient Care
A collaborative program discussing advances in cancer research
and healthy brain aging
Monday, August 6, 2012
8:30 a.m. – Registration and light breakfast
9:00 a.m. to Noon – Program
15 Peabody Drive
Northeast Harbor, Maine
Barbara Hannon, R.N., M.S.N., M.Ed., NE-BC, CENP
Vice President of Nursing, Mount Desert Island Hospital
J. Larry Jameson, M.D., Ph.D.
Executive Vice President, University of Pennsylvania for the Health System
Dean, Perelman School of Medicine
Edward B. Gilmore, M.D., MACP
Chief of Medicine, Mount Desert Island Hospital
People are living longer, but are they living better? Dr. Gilmore will discuss improving and extending the quality of life for older adults.
"Practical Tips for Successful Brain Aging"
John Q. Trojanowski, M.D., Ph.D.
William Maul Measey-Truman G. Schnabel, Jr., M.D.,
Professor of Geriatric Medicine and Gerontology
Director, Institute on Aging
Co-director, Center for Neurodegenerative Disease Research
Director, Alzheimer's Disease Center
Director, Morris K. Udall Parkinson's Disease Research Center of Excellence
"Penn's Drug Discovery Program for Alzheimer's Disease"
Virginia M.-Y. Lee, Ph.D., M.B.A.
The John H. Ware 3rd Professor in Alzheimer's Research
Director, Center for Neurodegenerative Disease Research
Leading University of Pennsylvania brain experts Drs. Trojanowski and Lee will share strategies for managing the progress of neuro-degenerative disorders like Alzheimer's, as well as tips for promoting healthy brain aging and memory. They will also describe their pioneering academic drug discovery program and how their latest promising advances in finding therapies for Alzheimer's can lead to similar breakthroughs for Parkinson's, amyotrophic lateral sclerosis (Lou Gehrig's disease), and frontotemporal degeneration.
"The Art of Prognosis – Providing Hope"
Philip L. Brooks, M.D.
Medical Oncologist, Cancer Care of Maine
Hope is an essential facet of the therapeutic relationship between cancer patients and their caregivers. Dr. Brooks will discuss the concept of "realistic hope," the importance of communication with patients receiving a cancer diagnosis, the ongoing advances in treatment, and the extraordinary patients he has encountered over his long career.
"Innovative, Individualized Cancer Prevention and Care"
Chi Van Dang, M.D., Ph.D.
John H. Glick M.D. Abramson Cancer Center Director's Professor
Director, Abramson Cancer Center
Carl H. June, M.D.
Richard W. Vague Family Professor in Immunotherapy
Director, Translational Research at the Abramson Cancer Center
Personalized medicine and the use of genomics are leading the way in the prevention, diagnosis, and treatment of disease. Drs. Dang and June will discuss Penn Medicine's recent headline-making breakthrough in cancer immuno-therapy, the promise of proton radiation and other new targeted therapies, and the many other encouraging implications personalized medicine holds for preventing and curing cancer.